Suchergebnisse - "Lin, Nan"

PubPharm (18)

1

Aumolertinib effectively reduces clinical symptoms of an EGFR L858R-mutant non-small cell lung cancer case coupled with osimertinib-induced severe thrombocytopenia : a case report

enthalten in: Anti-cancer drugs | 2023

von Hu, Y. | Quan, Y. | Duan, Y. | +6

2

Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus

enthalten in: Bioorganic & medicinal chemistry letters | 2017

von Shaw, S. | Goff, D. | Lin, N. | +6

3

UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines

enthalten in: BMC cancer | 2013

von Wu, G. | Lin, N. | Xu, L. | +2

ErratumIn: BMC Cancer. 2014;14:216 Feitelson, Mark A [added]

4

NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats

enthalten in: American journal of physiology. Cell physiology | 2011

von Lin, N. | Chen, S. | Pan, W. | +3

5

Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors

enthalten in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2008

von Xiao, Z. | Xue, J. | Gu, W. | +6

6

Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2007

von Li, G. | Tao, Z. | Tong, Y. | +8

7

Macrocyclic ureas as potent and selective Chk1 inhibitors : an improved synthesis, kinome profiling, structure-activity relationships, and preliminary pharmacokinetics

enthalten in: Bioorganic & medicinal chemistry letters | 2007

von Tao, Z. | Chen, Z. | Bui, M. | +7

8

Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2007

von Tao, Z. | Li, G. | Tong, Y. | +11

9

Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors : improving oral biovailability

enthalten in: Bioorganic & medicinal chemistry letters | 2007

von Tong, Y. | Przytulinska, M. | Tao, Z. | +16

10

Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors

enthalten in: Journal of medicinal chemistry | 2007

von Wang, L. | Sullivan, G. | Hexamer, L. | +20